Karlin and Cross (January 2014) described innovations in disseminating evidencebased psychotherapies in the Veterans Health Administration (VHA), including therapies for posttraumatic stress disorder (PTSD), a complex and chronic disorder among veterans. The multidimensional model they presented aims to promote the delivery of evidence-based psychotherapies nationally in order to redress the research-to-practice gap reflected in the infrequent use of evidence-based psychotherapies for PTSD in the VHA (Shiner et al., 2013) . In our view, however, the validity of this otherwise worthy strategic goal is built upon the questionable assumption that there is strong and sufficient evidence to support the use of the therapies being disseminated.
Two PTSD treatments-prolonged exposure (PE) and cognitive processing therapy (CPT)-were selected for systemwide dissemination, and VHA guidelines mandate that all veterans with PTSD have access to PE or CPT. Although several large-scale trials are currently ongoing, few treatment outcome studies of PE and CPT for military-related PTSD have been published, and most have been small-sample open trials (see Steenkamp & Litz, 2013) . Two randomized controlled trials (RCTs)-the traditional gold standard of treatment outcome studies-of individual PE and three RCTs of individual CPT in veterans have been published. Of these, only one examined VHA patients receiving PE or CPT for combat-related PTSD (Monson et al., 2006) . The remaining four were either international studies with marked contextual differences from VHA care or studies involving sexual trauma. Although important, RCTs of sexual trauma among primarily women veterans (two of which have been published, Schnurr et al., 2007, and Surís, Link-Malcolm, Chard, Ahn, & North, 2013) do not speak to the modal trauma treated by the VHA, namely, combat trauma among male veterans.
The general finding across all RCTs is that individual PE and CPT work in that they reduce military-related PTSD symptoms. However, it is less clear whether PE and CPT work well, that is, decrease symptoms to the point of low impairment and distress. Across studies, at least half of, but typically most, veterans still meet diagnostic criteria for PTSD following treatment. For example, at one-month follow-up in the Monson et al. (2006) trial, over two thirds (70%) of participants in the CPT intent-to-treat condition (drop-out from CPT was 20%) retained their PTSD diagnosis. It is also unclear whether treatments work reliably. Metrics of meaningful change show considerable variability in outcomes: Some patients improve substantially and some very little. PE and CPT thus do not have uniform effects and are not effective for all patients.
Perhaps more important for the dissemination of PE and CPT, which rests on the assumption of the superiority of these treatments over other psychotherapies, is the question of how PE and CPT have fared when compared with other active therapies, such as present-centered therapy (PCT). Of the three RCTs that have compared individual PE and CPT with PCT in veterans, findings have yet to demonstrate clear superiority of PE and CPT. In the Surís et al. (2013) trial, CPT was not superior to PCT on primary outcomes (clinician-assessed PTSD scores), and in the case of Schnurr et al. (2007) , initial differences between PE and PCT on primary outcomes were not maintained at a six-month follow-up. The one exception, a trial of CPT versus treatment as usual in Australian veterans (Forbes et al., 2012) , demonstrated more robust between-group differences but did not assess differences beyond a threemonth follow-up. Thus, the assumption that "evidence-based" PTSD care in veterans is markedly superior to PCT has yet to be borne out by the evidence.
In sum, rather than being highly effective for most veterans who receive them, in clinical trials, PE and CPT do not sufficiently or reliably meet the treatment needs of many veterans, and their incremental value over non-trauma-focused therapies remains unclear. Although PE and CPT are useful and important for clinicians to learn, even if the dissemination is highly successful, a significant portion of veterans with PTSD will require alternative or additional treatment. As such, dissemination should include contingencies that recognize the limitations of available evidence-based treatments, particularly if the evidence base also demonstrates clear shortcomings to these treatments' effectiveness, acceptability, and tolerability. For example, flexible application of a range of therapeutic strategies (including approaches that are supportive and focused on daily stressors, which RCTs show can be helpful) may better meet the needs of a broader range of veterans. Overall, dissemination models must move beyond simple onesize-fits-all conceptualizations of treatment if they are to adequately reflect the evidence base and the complexity of PTSD in veteran populations. The efforts of the Department of Veterans Affairs (VA) to identify guidelines for the application of evidence-based psychotherapies (EBPs) include comprehensive training for psychologists in certain EBPs, such as prolonged exposure therapy and cognitive processing therapy, and a multisystemic approach and support for introducing evidencebased guidelines in clinical practice. Disseminating research-based treatments to the largest health care system in the United States is certainly impressive and represents a welcome shift bringing science to clinical practice. Because the Veterans Health Administration (VHA) is so large, its policies have a broad influence on the training of psychologists as a whole. However well-intentioned these guidelines are, a group of 19 current and recent past presidents of three APA divisions (12, 29, and 50) and the North American and International Societies for Psychotherapy Research have recently expressed the concern that these guidelines may be short-sighted in several respects (Holt et al., 2013) . Speaking on behalf of these scholars, we have concerns stemming primarily from how the VA defines EBPs. The article by Karlin and Cross (January 2014) alluded to some of the controversies surrounding EBPs and why they have not been broadly implemented in many settings. For example, EBP guidelines often are perceived as mechanistic and only appropriate for certain patient populations; and, indeed, for many troubled individuals, EBPs do not work or require adjustment.
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Our group has identified several questions, the answers to which may be important to increase the optimization of such guidelines: What selection criteria does the VA use to define what EBPs are appropriate for veterans? If the criterion is diagnosis, is that sufficient? How do the VA guidelines account for differential response to treatment within diagnostic groups? Does the VA encourage clinicians to use cross-cutting and integrative treatments in ways that have been shown to enhance treatment outcomes? How do these decisions affect the education and training of psychologists?
In reviewing the VA and Department of Defense (DoD) guidelines, we came to believe that the VA's criteria for identifying evidence-based treatments, like most such lists, place undue weight both on the role of patient diagnosis and on the outcomes of randomized control trials (RCTs). From these types of outcome studies we know that many therapies are efficacious when compared with no treatment, but RCT studies lend themselves to the interpretation that there are some identified treatments that are superior to treatment as usual or to other RCT treatments, when in reality very few specific interventions have been found to be more efficacious than others for treating specific disorders or diagnostic groups. The VA standards acknowledge that the question of whether the EBPs will be effective in practice and not just in RCTs has not been fully answered; many factors affect a possible disparity in positive outcome between results from an RCT and actual practice (e.g., comorbidities, age, veteran vs. civilian sample; as older adults, veterans, and those with comorbid diagnoses are often not included in RCTs). This echoes our concern that veterans treated within the VHA may not respond to an EBP in the same way or to the same degree that patients have in RCT protocols. We believe that guidelines must do more to address the problems that arise when EBPs do not work or are not appropriate for a given patient.
As the largest health care network in the country and the largest training environment for psychologists (Karlin & Cross, 2014) , the VA, through its policies, has great influence over the field of clinical psychology. The VA and the DoD have given preference to several treatments for disorders such as posttraumatic stress disorder and major depression, based on their EBP selection criteria. We are concerned that the best practices in clinical psychology will come to reflect the VA guidelines for selecting treatments based on diagnosis and the outcome of RCTs rather than emerging from training psychologists to differentially select and adjust treatment based on individual client characteristics. We encourage the VA to discuss the broad implications of their policies on the training of mental health professionals.
Our article in The Clinical Psychologist (Holt et al., 2013) discussed the use of principles of change and cross-cutting techniques to individualize treatment in a way that have been shown to produce differential outcomes. Authors McHugh and Barlow (2010) argued that the VA guidelines are flexible and allow the clinician to implement the treatment in a way that best suits an individual patient. However, there are no research-informed guidelines provided for tailoring treatment to an individual patient as this conclusion would require. The Karlin and Cross (2014) article discussed how individualization of treatment is highlighted when nonspecific factors are implemented, but we argue that one can also individualize treatment, using combinations of specific factors (e.g., techniques and strategies) in a way that remains evidence supported.
Our recommendations to strengthen the VA guidelines include taking into account findings that have developed from practiceoriented research. One such recommendation involves using outcome measures and patient feedback to continually adjust treatment, which has been shown to prevent patient deterioration and dropout (Lambert & Shimokawa, 2011) . We also recommend using empirically based principles of change, such as those specified by Castonguay and Beutler (2006) and reinforced by Norcross (2011), rather than prepackaged treatments or specific theoretical orientations. The princiThis document is copyrighted by the American Psychological Association or one of its allied publishers.
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Monson, C. M., Schnurr, P. P., Resick, P. Defense, 2010) lists EMDR therapy as an "A" level treatment, described as "A strong recommendation that clinicians provide the intervention to eligible patients" (p. 202). According to the recently published practice guidelines of the World Health Organization (2013), trauma-focused cognitive behavioral therapy (CBT) and EMDR are the only therapies recommended for children, adolescents, and adults with PTSD. However, major differences exist between the two treatments: "Unlike CBT with a trauma focus, EMDR does not involve (a) detailed descriptions of the event, (b) direct challenging of beliefs, (c) extended exposure, or (d) homework" (World Health Organization, 2013, p. 1) These factors can make EMDR therapy easier for veteran treatment, as can be seen by the differences in retention rates and outcomes for CBT and EMDR.
Initial research using EMDR with military personnel found that EMDR led to remission of PTSD symptoms in 78% of soldiers, with positive effects maintained at follow-up (Carlson, Chemtob, Rusnack, Hedlund, & Muraoka, 1998 A growing body of evidence over the last 20 years has shown that EMDR provides effective trauma treatment for civilians, yet the VA has not conducted any EMDR research. Instead they have focused on pharmaceuticals, CPT and PE, and alternative therapies for PTSD including the use of pets, acupuncture, transcendental meditation, the "emotional freedom technique," tai chi, art therapy, Reiki, yoga, and pharmaceutical agents (Government Accountability Office, 2011). Drugs studied include derivations of such drugs as marijuana and ecstasy. Treating PTSD with medication has not been found effective. In fact, psychoactive prescription drugs have been implicated as one of the causative agents of the high rate of suicide of our troops. Antidepressants have been linked to suicidal thoughts and behaviors, and black box warnings alert consumers and prescribers to these risks. Of those veterans with PTSD, 80% were given psychoactive drugs, and 89% of these were prescribed antidepressants (Mohamed & Rosenheck, 2008) . Meanwhile, the VA has ignored research supporting that EMDR is a more effective treatment for sustained symptom relief for PTSD than are antidepressants. In one study, both PTSD and depressive symptoms were lower at six-month follow-up for those treated with EMDR than for those treated with Prozac (van der Kolk et al., 2007) . A more recent study found that five months after treatment, 60% of those on medication and 58% of those who received placebo still had PTSD, compared with only 20% of those who received psychotherapy (Shalev et al., 2012) . So why give medications at all when a sugar pill is just as effective without all the side effects? It is time to stop simply prescribing and to start providing evidence-based treatment. The VA needs to develop a strong research and clinician training program for EMDR on a par with current research and training programs for CPT and PE.
How sad that our veterans do not have a choice of those psychotherapies that truly are evidence-based. Our soldiers deserve better. More soldiers have committed suicide than have died in the war in Afghanistan. The military/veteran mental health system is being overwhelmed and needs all the evidence-based psychotherapies as treatments to alleviate human suffering and counteract the enormous wave of tragic outcomes due to PTSD. In 2012, the Surgeon General of the Navy called for more research on EMDR. There is an ethical mandate and a moral responsibility to provide our troops with all the best psychotherapies available. EMDR is one of the most potent evidence-based therapies and should be available for the treatment of PTSD for all veterans and active duty service men and women.
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